Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Sell
10,498
-224
-2% -$5.29K 0.05% 180
2025
Q4
$286K Hold
10,722
0.06% 156
2025
Q3
$325K Hold
10,722
0.07% 126
2025
Q2
$336K Hold
10,722
0.08% 120
2025
Q1
$410K Sell
10,722
-7,616
-42% -$323K 0.11% 104
2024
Q4
$805K Sell
18,338
-4,824
-21% -$212K 0.2% 71
2024
Q3
$997K Buy
23,162
+3,244
+16% +$145K 0.26% 59
2024
Q2
$900K Buy
19,918
+6,147
+45% +$319K 0.25% 65
2024
Q1
$860K Buy
13,771
+932
+7% +$55.8K 0.25% 67
2023
Q4
$719K Buy
+12,839
New +$640K 0.24% 69

Other funds holding ENOV

Auxano Advisors's ENOV Position: Q1 2026 in Review

Auxano Advisors reduced its Enovis (ENOV) stake by 2.1% in Q1 2026, selling an estimated $5.29K and leaving 10,498 shares worth $239K. The position accounts for 0.05% of the portfolio, ranked #180.

Auxano Advisors first reported a position in ENOV in Q4 2023 and has held it in 10 quarters since. The position peaked at $997K in Q3 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Auxano Advisors held 10,498 shares of Enovis worth $239K as of Q1 2026.
  • Auxano Advisors sold 224 Enovis shares in Q1 2026, an estimated $5.29K.
  • Enovis made up 0.05% of Auxano Advisors's portfolio in Q1 2026, its #180 holding.
  • Auxano Advisors first reported a position in Enovis in Q4 2023 and has held it in 10 quarters since.
  • Auxano Advisors's Enovis position peaked at $997K in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Auxano Advisors's 13F filing for Q1 2026, filed 4 May 2026.